{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:42:28Z","timestamp":1793295748962,"version":"4.5.0"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Ministry of University and Research"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Patients with type 2 diabetes mellitus (T2DM) and no significant carotid stenosis are often considered at moderate cardiovascular risk. However, some may harbour biologically active plaques. Intra-plaque vascularization (IPV), detectable in contrast-enhanced ultrasound (CEUS), reflects plaque vulnerability and may enhance risk stratification. We assessed the prognostic value of CEUS-derived IPV and the effects of SGLT2 inhibitors (SGLT2i) on cardiovascular outcomes and inflammatory markers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>In this 6-year prospective cohort study, 251 asymptomatic T2DM patients with carotid atherosclerosis &amp;lt;50% stenosis were enrolled. IPV was quantified by CEUS and stratified by tertiles. The primary endpoint was major adverse cardiovascular events (MACE: CV death, non-fatal MI, non-fatal stroke, or heart failure hospitalization). Secondary endpoints included changes in VEGF, IL-6, and TNF-\u03b1 levels. Patients were also stratified by chronic SGLT2i use. High IPV was associated with greater MACE incidence (32.5%) compared with low IPV (7.4%; HR 3.84, 95% CI 1.89\u20137.78; P &amp;lt; 0.001). SGLT2i-treated patients showed reduced MACE incidence (12.1% vs. 26.3%, P = 0.004), particularly in the high-IPV subgroup (23.1% vs. 38.9%; HR 0.48, 95% CI 0.25\u20130.91; P = 0.026). Treatment was also linked to significant VEGF (\u221252.4 vs. \u221218.6\u2005pg\/mL) and IL-6 (\u22121.9 vs. \u22120.6\u2005pg\/mL) reductions (P &amp;lt; 0.001 for both).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>CEUS-detected IPV predicts cardiovascular events in T2DM patients without significant stenosis. SGLT2i may reduce risk by modulating plaque inflammation and angiogenesis. CEUS combined with biomarker profiling may support personalized prevention strategies in diabetes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ehjimp\/qyaf129","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T11:35:44Z","timestamp":1761046544000},"source":"Crossref","is-referenced-by-count":1,"title":["Intra-plaque vascularization assessed in contrast-enhanced ultrasound predicts cardiovascular events in type 2 diabetes with no significant carotid atherosclerotic stenosis: a prospective study with therapeutic implications for SGLT2 inhibitor use"],"prefix":"10.1093","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3960-9270","authenticated-orcid":false,"given":"Raffaele","family":"Marfella","sequence":"first","affiliation":[{"name":"Department of Advanced Medical and Surgical Sciences, University of Campania \u2018Luigi Vanvitelli\u2019 , Naples ,","place":["Italy"]},{"name":"Pollution and Cardiovascular Diseases Research Centre, University of Campania \u2018Luigi Vanvitelli\u2019 , Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovica Vittoria","family":"Marfella","sequence":"additional","affiliation":[{"name":"Department of Advanced Medical and Surgical Sciences, University of Campania \u2018Luigi Vanvitelli\u2019 , Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Fumagalli","sequence":"additional","affiliation":[{"name":"Department of Advanced Medical and Surgical Sciences, University of Campania \u2018Luigi Vanvitelli\u2019 , Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Rinaldi","sequence":"additional","affiliation":[{"name":"Department of Advanced Medical and Surgical Sciences, University of Campania \u2018Luigi Vanvitelli\u2019 , Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdinando Carlo","family":"Sasso","sequence":"additional","affiliation":[{"name":"Department of Advanced Medical and Surgical Sciences, University of Campania \u2018Luigi Vanvitelli\u2019 , Naples ,","place":["Italy"]},{"name":"Pollution and Cardiovascular Diseases Research Centre, University of Campania \u2018Luigi Vanvitelli\u2019 , Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Cozzolino","sequence":"additional","affiliation":[{"name":"Department of Advanced Medical and Surgical Sciences, University of Campania \u2018Luigi Vanvitelli\u2019 , Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Nappo","sequence":"additional","affiliation":[{"name":"Department of Advanced Medical and Surgical Sciences, University of Campania \u2018Luigi Vanvitelli\u2019 , Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ausilia","family":"Sellitto","sequence":"additional","affiliation":[{"name":"Department of Advanced Medical and Surgical Sciences, University of Campania \u2018Luigi Vanvitelli\u2019 , Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciro","family":"Romano","sequence":"additional","affiliation":[{"name":"Department of Advanced Medical and Surgical Sciences, University of Campania \u2018Luigi Vanvitelli\u2019 , Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Carusone","sequence":"additional","affiliation":[{"name":"Department of Advanced Medical and Surgical Sciences, University of Campania \u2018Luigi Vanvitelli\u2019 , Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Diodato","sequence":"additional","affiliation":[{"name":"Department of Advanced Medical and Surgical Sciences, University of Campania \u2018Luigi Vanvitelli\u2019 , Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Russo","sequence":"additional","affiliation":[{"name":"Department of Advanced Medical and Surgical Sciences, University of Campania \u2018Luigi Vanvitelli\u2019 , Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenza","family":"Marfella","sequence":"additional","affiliation":[{"name":"Department of Advanced Medical and Surgical Sciences, University of Campania \u2018Luigi Vanvitelli\u2019 , Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola Maria","family":"Tarantino","sequence":"additional","affiliation":[{"name":"Department of Precision Medicine, University of Campania \u2018Luigi Vanvitelli\u2019 , Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo","family":"Carpinella","sequence":"additional","affiliation":[{"name":"Department of Cardiology, AORN Antonio Cardarelli , Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulvio","family":"Furbatto","sequence":"additional","affiliation":[{"name":"Department of Cardiology, AORN Antonio Cardarelli , Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Gentile","sequence":"additional","affiliation":[{"name":"Department of Clinical Research, Nefrocenter Research Network , Via XXV Luglio, 160 Cava de Tirreni, Salerno, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"Guarino","sequence":"additional","affiliation":[{"name":"Department of Clinical Research, Nefrocenter Research Network , Via XXV Luglio, 160 Cava de Tirreni, Salerno, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ersilia","family":"Satta","sequence":"additional","affiliation":[{"name":"Department of Clinical Research, Nefrocenter Research Network , Via XXV Luglio, 160 Cava de Tirreni, Salerno, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Bellis","sequence":"additional","affiliation":[{"name":"Department of Cardiology, AORN Antonio Cardarelli , Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Marinelli","sequence":"additional","affiliation":[{"name":"Department of Precision Medicine, University of Campania \u2018Luigi Vanvitelli\u2019 , Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Donisi","sequence":"additional","affiliation":[{"name":"Department of Precision Medicine, University of Campania \u2018Luigi Vanvitelli\u2019 , Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nunzia","family":"D\u2019Onofrio","sequence":"additional","affiliation":[{"name":"Pollution and Cardiovascular Diseases Research Centre, University of Campania \u2018Luigi Vanvitelli\u2019 , Naples ,","place":["Italy"]},{"name":"Department of Precision Medicine, University of Campania \u2018Luigi Vanvitelli\u2019 , Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciro","family":"Mauro","sequence":"additional","affiliation":[{"name":"Department of Cardiology, AORN Antonio Cardarelli , Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Cappabianca","sequence":"additional","affiliation":[{"name":"Department of Precision Medicine, University of Campania \u2018Luigi Vanvitelli\u2019 , Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luisa","family":"Balestrieri","sequence":"additional","affiliation":[{"name":"Pollution and Cardiovascular Diseases Research Centre, University of Campania \u2018Luigi Vanvitelli\u2019 , Naples ,","place":["Italy"]},{"name":"Department of Precision Medicine, University of Campania \u2018Luigi Vanvitelli\u2019 , Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celestino","family":"Sardu","sequence":"additional","affiliation":[{"name":"Department of Advanced Medical and Surgical Sciences, University of Campania \u2018Luigi Vanvitelli\u2019 , Naples ,","place":["Italy"]},{"name":"Pollution and Cardiovascular Diseases Research Centre, University of Campania \u2018Luigi Vanvitelli\u2019 , Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,10,23]]},"reference":[{"key":"2025112813022856700_qyaf129-B1","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1161\/CIRCULATIONAHA.116.022194","article-title":"Clinical update: cardiovascular disease in diabetes mellitus: atherosclerotic cardiovascular disease and heart failure in type 2 diabetes mellitus\u2014 mechanisms, management, and clinical considerations","volume":"133","author":"Low Wang","year":"2016","journal-title":"Circulation"},{"key":"2025112813022856700_qyaf129-B2","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1056\/NEJMoa1800256","article-title":"Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes","volume":"379","author":"Rawshani","year":"2018","journal-title":"N Engl J Med"},{"key":"2025112813022856700_qyaf129-B3","first-page":"1079","article-title":"Prevalence, impact, and predictive value of carotid artery plaque in patients with type 2 diabetes mellitus","volume":"120","author":"Baber","year":"2017","journal-title":"Am J Cardiol"},{"key":"2025112813022856700_qyaf129-B4","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jcmg.2012.03.013","article-title":"Carotid plaque burden as a measure of subclinical atherosclerosis: comparison with other tests for subclinical arterial disease in the high risk plaque BioImage study","volume":"5","author":"Sillesen","year":"2012","journal-title":"JACC Cardiovasc Imaging"},{"key":"2025112813022856700_qyaf129-B5","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1161\/CIRCULATIONAHA.109.887497","article-title":"Composition of carotid atherosclerotic plaque is associated with cardiovascular outcome: a prognostic study","volume":"121","author":"Hellings","year":"2010","journal-title":"Circulation"},{"key":"2025112813022856700_qyaf129-B6","first-page":"1","article-title":"Pathology of human carotid atheroma","volume":"2011","author":"Michel","year":"2011","journal-title":"Med Inflamm"},{"key":"2025112813022856700_qyaf129-B7","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jacc.2006.02.068","article-title":"Contrast ultrasound imaging of the carotid artery vasa vasorum and atherosclerotic plaque neovascularization","volume":"48","author":"Feinstein","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2025112813022856700_qyaf129-B8","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jacc.2008.02.082","article-title":"Contrast-enhanced ultrasound imaging of intraplaque neovascularization in carotid arteries: correlation with histology and plaque echogenicity","volume":"52","author":"Coli","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2025112813022856700_qyaf129-B9","first-page":"550","article-title":"Carotid intima-media thickness and risk of stroke and myocardial infarction","volume":"14","author":"Della-Morte","year":"2012","journal-title":"Curr Cardiol Rep"},{"key":"2025112813022856700_qyaf129-B10","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1152\/physrev.00006.2013","article-title":"Postischemic revascularization: from cellular and molecular mechanisms to clinical applications","volume":"93","author":"Silvestre","year":"2013","journal-title":"Physiol Rev"},{"key":"2025112813022856700_qyaf129-B11","first-page":"371","article-title":"Inflammatory markers and neovascularization in human carotid plaques","volume":"147","author":"Di Stefano","year":"2011","journal-title":"Int J Cardiol"},{"key":"2025112813022856700_qyaf129-B12","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nri1882","article-title":"The immune response in atherosclerosis: a double-edged sword","volume":"6","author":"Hansson","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"2025112813022856700_qyaf129-B13","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.acvd.2016.04.002","article-title":"Inflammation in atherosclerosis","volume":"109","author":"Taleb","year":"2016","journal-title":"Arch Cardiovasc Dis"},{"key":"2025112813022856700_qyaf129-B14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(18)32590-X","article-title":"SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a meta-analysis of cardiovascular outcomes trials","volume":"393","author":"Zelniker","year":"2019","journal-title":"Lancet"},{"key":"2025112813022856700_qyaf129-B15","first-page":"45","article-title":"Empagliflozin attenuates atherosclerosis in apolipoprotein E knockout mice by reducing inflammation and oxidative stress","volume":"20","author":"Nasiri-Ansari","year":"2021","journal-title":"Hormones"},{"key":"2025112813022856700_qyaf129-B16","first-page":"1974","article-title":"The SGLT2 inhibitor dapagliflozin has a protective effect on endothelial function in diabetic rats","volume":"9","author":"Leng","year":"2016","journal-title":"Int J Clin Exp Pathol"},{"key":"2025112813022856700_qyaf129-B17","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1111\/dom.15454","article-title":"Sodium-glucose co-transporter 2 inhibitor therapy reduces the administration frequency of anti-vascular endothelial growth factor agents in patients with diabetic macular oedema with a history of anti-vascular endothelial growth factor agent use: a cohort study using the Japanese health insurance claims database","volume":"26","author":"Ishibashi","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"2025112813022856700_qyaf129-B18","first-page":"H850","article-title":"SGLT2 inhibition via dapagliflozin improves endothelial function and reduces vascular stiffness in aged mice","volume":"318","author":"Lee","year":"2020","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2025112813022856700_qyaf129-B19","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1148\/radiol.2292030516","article-title":"Carotid artery stenosis: gray-scale and Doppler US diagnosis\u2014society of radiologists in ultrasound consensus conference","volume":"229","author":"Grant","year":"2003","journal-title":"Radiology"},{"key":"2025112813022856700_qyaf129-B20","first-page":"25","article-title":"Biomarkers of atherosclerosis: clinical applications and limitations","volume":"3","author":"Ferroni","year":"2012","journal-title":"J Blood Med"},{"key":"2025112813022856700_qyaf129-B21","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.jacc.2017.12.048","article-title":"2017 cardiovascular and stroke endpoint definitions for clinical trials","volume":"71","author":"Hicks","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2025112813022856700_qyaf129-B22","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/sj.bjc.6601119","article-title":"Survival analysis part II: multivariate data analysis\u2014an introduction to concepts and methods","volume":"89","author":"Bradburn","year":"2003","journal-title":"Br J Cancer"},{"key":"2025112813022856700_qyaf129-B23","first-page":"2073","article-title":"Plaque neovascularization: a novel therapeutic target for atherosclerosis","volume":"48","author":"Moreno","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2025112813022856700_qyaf129-B24","first-page":"1189","article-title":"Intraplaque hemorrhage and sudden coronary death: new insights into pathogenesis","volume":"24","author":"Kolodgie","year":"2003","journal-title":"Eur Heart J"},{"key":"2025112813022856700_qyaf129-B25","doi-asserted-by":"crossref","first-page":"C13","DOI":"10.1016\/j.jacc.2005.10.065","article-title":"Pathology of the vulnerable plaque","volume":"47","author":"Virmani","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2025112813022856700_qyaf129-B26","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1161\/CIRCRESAHA.115.306884","article-title":"Vascular complications of diabetes","volume":"118","author":"Beckman","year":"2016","journal-title":"Circ Res"},{"key":"2025112813022856700_qyaf129-B27","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1172\/JCI119813","article-title":"Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia: intimal accumulation of LDL and its oxidation precede monocyte recruitment","volume":"100","author":"Napoli","year":"1997","journal-title":"J Clin Invest"},{"key":"2025112813022856700_qyaf129-B28","first-page":"96","article-title":"Cardiovascular actions of SGLT2 inhibitors: emerging evidence","volume":"20","author":"Caporali","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"2025112813022856700_qyaf129-B29","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jcmg.2010.02.007","article-title":"Contrast-enhanced ultrasound imaging of the vasa vasorum: from early atherosclerosis to the identification of unstable plaques","volume":"3","author":"Staub","year":"2010","journal-title":"JACC Cardiovasc Imaging"},{"key":"2025112813022856700_qyaf129-B30","first-page":"108803","article-title":"Contrast-enhanced ultrasound for the assessment of intraplaque neovascularization in carotid arteries: a systematic review and meta-analysis","volume":"124","author":"Xie","year":"2020","journal-title":"Eur J Radiol"},{"key":"2025112813022856700_qyaf129-B31","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"key":"2025112813022856700_qyaf129-B32","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and cardiovascular outcomes in type 2 diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N Engl J Med"},{"key":"2025112813022856700_qyaf129-B33","first-page":"e3410","article-title":"SGLT2 inhibitors suppress HIF-1\u03b1-mediated VEGF expression by inhibiting PI3\u2005K\/AKT signaling pathway in diabetic atherosclerosis","volume":"37","author":"Wang","year":"2021","journal-title":"Diabetes Metab Res Rev"},{"key":"2025112813022856700_qyaf129-B34","first-page":"111","article-title":"The beneficial effects of SGLT2 inhibitors on atherosclerosis: focus on autophagy and inflammasome modulation","volume":"20","author":"Han","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"2025112813022856700_qyaf129-B35","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nri2171","article-title":"Evolving functions of endothelial cells in inflammation","volume":"7","author":"Pober","year":"2007","journal-title":"Nat Rev Immunol"}],"container-title":["European Heart Journal - Imaging Methods and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjimp\/advance-article-pdf\/doi\/10.1093\/ehjimp\/qyaf129\/64906138\/qyaf129.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjimp\/article-pdf\/3\/4\/qyaf129\/64906138\/qyaf129.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjimp\/article-pdf\/3\/4\/qyaf129\/64906138\/qyaf129.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T18:02:38Z","timestamp":1764352958000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjimp\/article\/doi\/10.1093\/ehjimp\/qyaf129\/8300498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,10,6]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjimp\/qyaf129","relation":{},"ISSN":["2755-9637"],"issn-type":[{"value":"2755-9637","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,10]]},"published":{"date-parts":[[2025,10]]},"article-number":"qyaf129"}}